vs
CoStar Group（CSGP）与Encompass Health Corp（EHC）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是CoStar Group的1.7倍（$1.5B vs $899.9M），Encompass Health Corp净利率更高（9.5% vs 5.2%，领先4.3%），CoStar Group同比增速更快（26.9% vs 9.9%），Encompass Health Corp自由现金流更多（$116.7M vs $101.3M），过去两年CoStar Group的营收复合增速更高（17.1% vs 8.3%）
CoStar Group是1987年成立的美国商业地产服务商，总部位于弗吉尼亚州阿灵顿，业务覆盖北美、欧洲地区，为商业地产行业提供信息、分析及营销解决方案，旗下运营CoStar线上数据库、新闻网站及Apartments.com、Homes.com等多个线上平台。
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
CSGP vs EHC — 直观对比
营收规模更大
EHC
是对方的1.7倍
$899.9M
营收增速更快
CSGP
高出16.9%
9.9%
净利率更高
EHC
高出4.3%
5.2%
自由现金流更多
EHC
多$15.4M
$101.3M
两年增速更快
CSGP
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $899.9M | $1.5B |
| 净利润 | $46.5M | $146.1M |
| 毛利率 | 78.6% | — |
| 营业利润率 | 5.5% | 16.7% |
| 净利率 | 5.2% | 9.5% |
| 营收同比 | 26.9% | 9.9% |
| 净利润同比 | -22.2% | 20.8% |
| 每股收益（稀释后） | $0.12 | $1.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSGPEHC
| Q4 25 | $899.9M | $1.5B | ||
| Q3 25 | $833.6M | $1.5B | ||
| Q2 25 | $781.3M | $1.5B | ||
| Q1 25 | $732.2M | $1.5B | ||
| Q4 24 | $709.4M | $1.4B | ||
| Q3 24 | $692.6M | $1.4B | ||
| Q2 24 | $677.8M | $1.3B | ||
| Q1 24 | $656.4M | $1.3B |
净利润CSGPEHC
| Q4 25 | $46.5M | $146.1M | ||
| Q3 25 | $-30.9M | $126.5M | ||
| Q2 25 | $6.2M | $142.1M | ||
| Q1 25 | $-14.8M | $151.5M | ||
| Q4 24 | $59.8M | $120.9M | ||
| Q3 24 | $53.0M | $108.2M | ||
| Q2 24 | $19.2M | $114.1M | ||
| Q1 24 | $6.7M | $112.5M |
毛利率CSGPEHC
| Q4 25 | 78.6% | — | ||
| Q3 25 | 79.3% | — | ||
| Q2 25 | 78.5% | — | ||
| Q1 25 | 79.1% | — | ||
| Q4 24 | 80.1% | — | ||
| Q3 24 | 79.7% | — | ||
| Q2 24 | 80.0% | — | ||
| Q1 24 | 78.5% | — |
营业利润率CSGPEHC
| Q4 25 | 5.5% | 16.7% | ||
| Q3 25 | -6.1% | 14.9% | ||
| Q2 25 | -3.5% | 16.2% | ||
| Q1 25 | -5.8% | 16.4% | ||
| Q4 24 | 5.6% | 14.3% | ||
| Q3 24 | 3.4% | 13.6% | ||
| Q2 24 | -2.4% | 14.3% | ||
| Q1 24 | -6.5% | 13.6% |
净利率CSGPEHC
| Q4 25 | 5.2% | 9.5% | ||
| Q3 25 | -3.7% | 8.6% | ||
| Q2 25 | 0.8% | 9.7% | ||
| Q1 25 | -2.0% | 10.4% | ||
| Q4 24 | 8.4% | 8.6% | ||
| Q3 24 | 7.7% | 8.0% | ||
| Q2 24 | 2.8% | 8.8% | ||
| Q1 24 | 1.0% | 8.5% |
每股收益（稀释后）CSGPEHC
| Q4 25 | $0.12 | $1.43 | ||
| Q3 25 | $-0.07 | $1.24 | ||
| Q2 25 | $0.01 | $1.39 | ||
| Q1 25 | $-0.04 | $1.48 | ||
| Q4 24 | $0.14 | $1.18 | ||
| Q3 24 | $0.13 | $1.06 | ||
| Q2 24 | $0.05 | $1.12 | ||
| Q1 24 | $0.02 | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6B | $72.2M |
| 总债务越低越好 | $140.0M | $2.4B |
| 股东权益账面价值 | $8.3B | $2.4B |
| 总资产 | $10.5B | $7.1B |
| 负债/权益比越低杠杆越低 | 0.02× | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资CSGPEHC
| Q4 25 | $1.6B | $72.2M | ||
| Q3 25 | $1.9B | $48.7M | ||
| Q2 25 | $3.6B | $99.1M | ||
| Q1 25 | $3.7B | $95.8M | ||
| Q4 24 | $4.7B | $85.4M | ||
| Q3 24 | — | $147.8M | ||
| Q2 24 | — | $154.4M | ||
| Q1 24 | — | $134.4M |
总债务CSGPEHC
| Q4 25 | $140.0M | $2.4B | ||
| Q3 25 | $1.0B | $2.4B | ||
| Q2 25 | $1.0B | $2.3B | ||
| Q1 25 | $1.0B | $2.3B | ||
| Q4 24 | $1.0B | $2.4B | ||
| Q3 24 | $1.0B | $2.3B | ||
| Q2 24 | $1.0B | $2.7B | ||
| Q1 24 | $1.0B | $2.7B |
股东权益CSGPEHC
| Q4 25 | $8.3B | $2.4B | ||
| Q3 25 | $8.6B | $2.4B | ||
| Q2 25 | $8.6B | $2.3B | ||
| Q1 25 | $8.6B | $2.2B | ||
| Q4 24 | $7.6B | $2.1B | ||
| Q3 24 | $7.5B | $2.0B | ||
| Q2 24 | $7.4B | $1.8B | ||
| Q1 24 | $7.3B | $1.7B |
总资产CSGPEHC
| Q4 25 | $10.5B | $7.1B | ||
| Q3 25 | $10.8B | $6.9B | ||
| Q2 25 | $10.5B | $6.8B | ||
| Q1 25 | $10.4B | $6.6B | ||
| Q4 24 | $9.3B | $6.5B | ||
| Q3 24 | $9.1B | $6.5B | ||
| Q2 24 | $9.1B | $6.4B | ||
| Q1 24 | $9.0B | $6.2B |
负债/权益比CSGPEHC
| Q4 25 | 0.02× | 1.00× | ||
| Q3 25 | 0.12× | 1.01× | ||
| Q2 25 | 0.12× | 1.02× | ||
| Q1 25 | 0.12× | 1.08× | ||
| Q4 24 | 0.13× | 1.14× | ||
| Q3 24 | 0.13× | 1.20× | ||
| Q2 24 | 0.14× | 1.46× | ||
| Q1 24 | 0.14× | 1.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $162.1M | $346.0M |
| 自由现金流经营现金流 - 资本支出 | $101.3M | $116.7M |
| 自由现金流率自由现金流/营收 | 11.3% | 7.6% |
| 资本支出强度资本支出/营收 | 6.8% | 14.8% |
| 现金转化率经营现金流/净利润 | 3.49× | 2.37× |
| 过去12个月自由现金流最近4个季度 | $123.0M | $439.2M |
8季度趋势，按日历期对齐
经营现金流CSGPEHC
| Q4 25 | $162.1M | $346.0M | ||
| Q3 25 | $68.2M | $270.8M | ||
| Q2 25 | $146.5M | $270.2M | ||
| Q1 25 | $53.2M | $288.6M | ||
| Q4 24 | $94.6M | $278.8M | ||
| Q3 24 | $100.3M | $267.8M | ||
| Q2 24 | $58.1M | $217.4M | ||
| Q1 24 | $139.6M | $238.8M |
自由现金流CSGPEHC
| Q4 25 | $101.3M | $116.7M | ||
| Q3 25 | $-5.5M | $83.7M | ||
| Q2 25 | $27.7M | $113.3M | ||
| Q1 25 | $-500.0K | $125.5M | ||
| Q4 24 | $25.2M | $80.1M | ||
| Q3 24 | $40.2M | $120.3M | ||
| Q2 24 | $-14.7M | $60.5M | ||
| Q1 24 | $-237.1M | $99.4M |
自由现金流率CSGPEHC
| Q4 25 | 11.3% | 7.6% | ||
| Q3 25 | -0.7% | 5.7% | ||
| Q2 25 | 3.5% | 7.8% | ||
| Q1 25 | -0.1% | 8.6% | ||
| Q4 24 | 3.6% | 5.7% | ||
| Q3 24 | 5.8% | 8.9% | ||
| Q2 24 | -2.2% | 4.6% | ||
| Q1 24 | -36.1% | 7.6% |
资本支出强度CSGPEHC
| Q4 25 | 6.8% | 14.8% | ||
| Q3 25 | 8.8% | 12.7% | ||
| Q2 25 | 15.2% | 10.8% | ||
| Q1 25 | 7.3% | 11.2% | ||
| Q4 24 | 9.8% | 14.1% | ||
| Q3 24 | 8.7% | 10.9% | ||
| Q2 24 | 10.7% | 12.1% | ||
| Q1 24 | 57.4% | 10.6% |
现金转化率CSGPEHC
| Q4 25 | 3.49× | 2.37× | ||
| Q3 25 | — | 2.14× | ||
| Q2 25 | 23.63× | 1.90× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | 1.58× | 2.31× | ||
| Q3 24 | 1.89× | 2.48× | ||
| Q2 24 | 3.03× | 1.91× | ||
| Q1 24 | 20.84× | 2.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSGP
| Co Star | $503.8M | 56% |
| Other | $283.0M | 31% |
| Loop Net | $94.7M | 11% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
